MRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation

Molecular Brain Research

Volumn 47, Issue 1-2, 1997, Pages 157-169

  Masos, Tamar ^a   Miskin, Ruth ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Brain blood vessel; Hypothalamus; Kainic acid; Limbic structure; Plasminogen activator inhibitor 1; Stroke risk; uPA mRNA and PAI 1 mRNA in mouse brain; Urokinase type plasminogen activator

Indexed keywords

ANTIFIBRINOLYTIC AGENT; KAINIC ACID; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERINE PROTEINASE; UROKINASE;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN REGION; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; FIBRINOLYSIS; GENE EXPRESSION; HIPPOCAMPUS; HYPOTHALAMUS; IN SITU HYBRIDIZATION; ISOTOPE LABELING; LIMBIC CORTEX; MOUSE; NERVE CELL PLASTICITY; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; RNA PROBE; STROKE; TISSUE REGENERATION;

ANIMALS; BRAIN; FEMALE; HYPOTHALAMUS; IN SITU HYBRIDIZATION; KAINIC ACID; MICE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030945560     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00040-5     Document Type: Article

References (66)

1. Akabayashi, A., Koenig, J.I., Watanabe, Y., Alexander, J.T. and Leibowitz, S.F., Galanin-containing neurons in the paraventricular nucleus: a neurochemical marker for fat ingestion and body weight gain, Proc. Natl. Acad. Sci. USA, 91 (1994) 10375-10379.
2. Andreasen, P.A., Georg, B., Lund, L.R., Riccio, A. and Stacey, S.N., Plasminogen activator inhibitors: hormonally regulated serpins, Mol. Cell. Endocrinol., 68 (1990) 1-19.
3. Amman, V., Nilsson, A., Stemme, S., Risberg, B. and Rymo, L., Expression of plasminogen activator inhibitor-1 mRNA in healthy, atherosclerotic and thrombotic human arteries and veins, Thrombosis Res., 76 (1994) 487-499.
4. Bacharach, E., Itin, A. and Keshet, E., In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis, Proc. Natl. Acad. Sci. USA, 89 (1992) 10686-10690.
5. Behrendt, N., Ronne, E. and Dano, K., The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface, Biol. Chem. Hoppe-Seyler, 376 (1995) 269-279.
6. Ben-Ari, Y., Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy, Neuroscience, 14 (1985) 375-403.
7. Ben-Ari, Y. and Represa, A., Brief seizure episodes induce long-term potentiation and mossy fibre sprouting in the hippocampus, Trends Neurosci., 13 (1990) 312-318.
8. Bugra, K., Pollard, H., Charton, G., Moreau, J., Ben-Ari, Y. and Khrestchatisky, M., aFGF, bFGF and fig mRNAs show distinct patterns of induction in the hippocampus following kainate-induced seizures, Eur. J. Neurosci., 6 (1994) 58-66.
9. Carmeliet, P. and Collen, D., Evaluation of the plasminogen/plasmin system in transgenic mice, Fibrinolysis, 8 (Suppl., 1) (1994) 269-276.
10. Carmeliet, P., Stassen, J.M., Schoonjans, L., Ream, B., Van den Oord, J.J., De Mol, M., Mulligan, R.C. and Collen, D., Plasminogen activator inhibitor-1 gene-deficient mice II. Effects on hemostasis, thrombosis, and thrombolysis, J. Clin. Invest., 92 (1993) 2756-2760.
11. Checler, F.P., Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease, J. Neurochem., 65 (1995) 1431-1444.
12. Chen, Z.-L., Yoshida, S., Kato, K., Momota, Y., Suzuki, J., Tanaka, T., Ito, J., Nishino, H., Aimoto, S., Kiyama, H. and Shiosaka, S., Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus, J. Neurosci., 15 (1995) 5088-5097.
13. Conese, M. and Blasi, F., Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation, Biol. Chem. Hoppe-Seyler, 376 (1995) 143-155.
14. Dudai, Y., The Neurobiology of Memory. Concepts, Findings, Trends, Oxford University Press, Oxford, UK, 1989.
15. Faber-Elman, A., Miskin, R. and Schwartz, M., Components of the plasminogen activator system in astrocytes are modulated by tumor necrosis factor-α and interleukin-1β through similar signal transduction pathways, J. Neurochem., 65 (1995) 1524-1535.
16. Frankish, H.M., Dryden, S., Hopkins, D., Wang, Q. and Williams, G., Neuropeptide Y, the hypothalamus, and diabetes: insights into the central control of metabolism, Peptides 16 (1995) 757-771.
17. A receptor gene expression in adult rat hippocampus: an in situ hybridization study, J. Neurosci., 14 (1994) 2697-2707.
18. Giardino, L, Ceccatelli, S., Hökfelt, T. and Calza, L., Expression of enkephalin and dynorphin precursor mRNAs in brain areas of hypo-and hyperthyroid rat: effect of kainic acid injection, Brain Res., 687 (1995) 83-93.
19. Gobbi, M., Monhemius, R., Samanin, R., Mennini, T. and Vezzani, A., Cellular localization of neuropeptide-Y receptors in the rat hippocampus: long-term effects of limbic seizures, NeuroReport, 7 (1996) 1475-1480.
20. Granelli-Piperno, A. and Reich, E., Plasminogen activators of the pituitary gland: enzyme characterization and hormonal modulation, J. Cell. Biol., 97 (1983) 1029-1037.
21. Hatzfeld, J., Miskin, R. and Reich, E., Acetylcholine receptor: effect of proteolysis on receptor metabolism, J. Cell. Biol., 92 (1982) 176-182.
22. Houenou, L.J., Turner, P.L., Li, L., Oppenheim, R.W. and Festoff, B.W., A serine protease inhibitor, protease nexin I, rescues motoneurons from naturally occurring and axotomy-induced cell death, Proc. Natl. Acad. Sci. USA, 92 (1995) 895-899.
23. Humpel, C., Hoffer, B., Strömberg, I., Betkesh, S., Collins, F. and Olson, L., Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation, Neuroscience, 59 (1994) 791-795.
24. Kalra, S.P., Dube, M.G., Sahu, A., Phelps, C.P. and Kalra, P.S., Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food, Proc. Natl. Acad. Sci. USA, 88 (1991) 10931-10935.
25. Kaminska, B., Filipkowski, R.K., Zurkowska, G., Lason, W., Przewlocki, R. and Kaczmarek, L., Dynamic changes in the composition of the AP-1 transcription factor DNA-binding activity in rat brain following kainate-induced seizures and cell death, Eur. J. Neurosci., 6 (1994) 1558-1566.
26. Liu, Y., Fields, R.D., Festoff, B.W. and Nelson, P.G., Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction, Proc. Natl. Acad. Sci. USA, 91 (1994) 10300-10304.
27. Liu, Y., Fields, R.D., Fitzgerald, S., Festoff, B.W. and Nelson, P.G., Proteolytic activity, synapse elimination, and the Hebb synapse, J. Neurobiol., 25 (1994) 325-335.
28. Loskutoff, D.J. Regulation of PAI-1 gene expression, Fibrinolysis, 5 (1991) 197-206.
29. Masos, T. and Miskin, R., Localization of urokinase-type plasminogen activator mRNA in the adult mouse brain, Mol. Brain Res., 35 (1996) 139-148.
30. Meiri, N., Masos, T., Rosenblum, K., Miskin, R. and Dudai, Y., Overexpression of urokinase-type plasminogen activator in transgenic mice is correlated with impaired learning, Proc. Natl. Acad. Sci. USA, 91 (1994) 3196-3200.
31. Miskin, R. and Abramovitz, R., One-phase reverse zymography after denaturing gel electrophoresis: high sensitivity detection of activity of plasminogen activator inhibitor 2 and other protease inhibitors, Fibrinolysis, 9 (1995) 331-342.
32. Miskin, R. and Masos, T., Transgenic mice overexpressing urokinase-type plasminogen activator in the brain exhibit reduced food consumption, body weight and size, and increased longevity, J. Gerontol., (in press).
33. Monard, D., Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth, Trends Neurosci., 11 (1988) 541-544.
34. Morley, J.E., Neuropeptide regulation of appetite and weight, Endoer. Rev., 8 (1987) 256-287.
35. Murtomäki, S., Trenkner, E., Wright, J.M., Saksela, O. and Liesi, P., Increased proteolytic activity of the granule neurons may contribute to neuronal death in the weaver mouse cerebellum, Dev. Biol., 168 (1995) 635-648.
36. Nerlov, C., De Cesare, D., Pergola, F., Caracciolo, A., Blasi, F., Johnsen, M. and Verde, P., A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells, EMBO J., 11 (1992) 4573-4582.
37. Nakajima, K., Nagata, K., Hamanoue, M., Takemoto, N. and Kohsaka, S., Microglia-derived elastase produces a low-molecular-weight plasminogen that enhances neurite outgrowth in rat neocortical expiant cultures, J. Neurochem., 61 (1993) 2155-2163.
38. Parkinson, W.L. and Weingarten, H.P., Dissociative analysis of ventromedial hypothalamic obesity syndrome, Am. J. Physiol., 259 (1990) R829-R835.
39. Pérez-Otaño, I., McMillian, M.K., Chen, J., Bing, G., Hong, J.S. and Pennypacker, K.R., Induction of NF-kB-like transcription factors in brain areas susceptible to kainate toxicity, Glia, 16 (1996) 306-315.
40. Pollard, H., Charriaut-Marlangue, C., Cantagrel, S., Represa, A., Robain, O., Moreau, J. and Ben-Ari, Y., Kainate-induced apoptotic cell death in hippocampal neurons, Neuroscience, 63 (1994) 7-18.
41. Pollard, H., Khrestchatisky, M., Moreau, J., Ben-Ari, Y. and Represa, A., Correlation between reactive sprouting and microtubule protein expression in epileptic hippocampus, Neuroscience, 61 (1994) 773-787.
42. Prendergast, G.C., Diamond, L.E., Dahl, D. and Cole, M.D., The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1, Mol. Cell. Biol., 10 (1990) 1265-1269.
43. Pyke, C., Kristensen, P., Ralfkiaer, E., Eriksen, J. and Dano, K., The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma, Cancer Res., 51 (1991) 4067-4071.
44. Qian, Z., Gilbert, M.E., Colicos, M.A., Kandel, E.R. and Kuhl, D., Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation, Nature, 361 (1993) 453-457.
45. Reznikov, K.Y., Cell Proliferation and Cytogenesis in the Mouse Hippocampus, Springer, Berlin, Germany, 1991, pp. 6-11.
46. Riccio, A., Pedone, P.V., Lund, L.R., Olesen, T., Olsen, H.S. and Andreasen, P.A., Transforming growth factor β1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene, Mol. Cell. Biol., 12 (1992) 1846-1855.
47. Rifkin, D.B., Moscatelli, D., Bizik, J., Quarto, N., Blei, F., Dennis, P., Flaumenhaft, R. and Mignatti, P., Growth factor control of extracellular proteolysis, Cell Differ. Dev., 32 (1990) 313-318.
48. Riva, M.A., Donati, E., Tascedda, F., Zolli, M. and Racagni, G., Short- and long-term induction of basic fibroblast growth factor gene expression in rat central nervous system following kainate injection, Neuroscience, 59 (1994) 55-65.
49. Roberts, R.M., Mathialagan, N., Duffy, J.Y. and Smith, G.W., Regulation and regulatory role of proteinase inhibitors, Crit. Rev. Eukaryotic Gene Expression, 5 (1995) 385-436.
50. Romanic, A.M. and Madri, J.A., Extracellular matrix-degrading proteinases in the nervous system, Brain Pathol., 4 (1994) 145-156.
51. Sakhi, S., Bruce, A., Sun, Ning, Tocco, G., Baudry, M. and Schreiber, S.S., p53 induction is associated with neuronal damage in the central nervous system, Proc. Natl. Acad. Sci. USA, 91 (1994) 7525-7529.
52. Saksela, O. and Rifkin, D.B., Cell-associated plasminogen activation: regulation and physiological functions, Annu. Rev. Cell. Biol., 4 (1988) 93-126.
53. Sappino, A.P., Madani, R., Huarte, J., Beline, D., Kiss, J.Z., Wohlwend, A. and Vassalli, J.V., Extracellular proteolysis in the adult murine brain, J. Clin. Invest., 92 (1993) 679-685.
54. Schneiderman, J. and Loskutoff, D.J., Plasminogen activator inhibitors, Trends Cardiovas. Med., 1 (1991) 99-102.
55. Schneiderman, J., Sawdey, M.S., Keeton, M.R., Bordin, G.M., Bernstein, E.F., Dilley, R.B. and Loskutoff, D.J., Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries, Proc. Natl. Acad. Sci. USA, 89 (1992) 6998-7002.
56. Sheng, M. and Greenberg, M.E., The regulation and function of c-fos and other immediate early genes in the nervous system, Neuron 4 (1990) 477-485.
57. Smirnova, I.V., Ho, G.J., Fenton, II, J.W. and Festoff, B.W., Extravascular proteolysis and the nervous system: serine protease/serpin balance, Semin. Thrombosis Hemostasis, 20 (1994) 426-432.
58. 2+ homeostasis and sensitivity to glucose deprivation-induced injury, J. Neurosci., 15 (1995) 5840-5850.
59. Solà, C., García-Ladona, F.J., Mengod, G., Probst, A., Frey, P. and Palacios, J.M., Increased levels of the Kunitz protease inhibitor-containing βAPP mRNAs in rat brain following neurotoxic damage, Mol. Brain Res., 17 (1993) 41-52.
60. Sperk, G., Kainic acid seizures in the rat, Prog. Neurobiol., 42 (1994) 1-32.
61. Sperk, G., Lassmann, H., Baran, H., Kish, S.R., Seitelberger, F. and Hornykiewicz, O., Kainic acid induced seizures: neurochemical and histopathological changes, Neuroscience, 10(1983) 1301-1315.
62. Suzuki, F., Junier, M.-P., Guilhem, D., Sorensen, J.-C. Onteniente, B., Morphogenetic effect of kainate on adult hippocampal neurons associated with a prolonged expression of brain-derived neurotrophic factor, Neuroscience, 64 (1995) 665-674.
63. Van den Pol, A.N., Wuarin, J.-P. and Dudek, F.E., Glutamate, the dominant excitatory transmitter in neuroendocrine regulation, Science, 250 (1990) 1276-1278.
64. Van der Wal, E.A., Gómez-Pinilla, F. and Cotman, C.W., Seizure-associated induction of basic fibroblast growth factor and its receptor in the rat brain, Neuroscience, 60 (1994) 311-323.
65. Vassalli, J.D., Sappino, A.P. and Belin, D., The plasminogen activator/plasmin system, J. Clin. Invest., 88 (1991) 1067-1072.
66. Wagner, S.L., Geddes, J.W., Cotman, C.W., Lau, A.L., Gurwitz, D., Isackson, P.J. and Cunningham, D.D., Protein nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease, Proc. Natl. Acad. Sci. USA, 86 (1989) 8284-8288.